HomeStock SectorsEnergy StocksOil Markets on Edge:...

Oil Markets on Edge: Analyzing the 52% Risk of Hormuz Disruption

could rise all the way to $100 and more, peaking at $110 per barrel in case Iran closes the Strait of Hormuz, Goldman Sachs said in a new note.

The investment bank said this price could materialize if oil flows via the vital chokepoint were cut by half for a month and remained 10% lower than normal over the next 11 months. This is a rather specific forecast that may not be the most likely scenario for developments of the Middle East but some disruption in oil flows seems all but certain at this point.

After the initial price shock under Goldman’s scenario, Brent would moderate to $95 per barrel over the final quarter of this year, the bank’s analysts also said, as quoted by Reuters. This is a substantial revision of an earlier forecast for oil prices made by the bank last week. Then, Goldman Sachs estimated a geopolitical premium of approximately $10 per barrel on Brent crude, though it suggested oil could exceed $90 if Iranian supply were disrupted.

The investment bank estimated the chance of Iran shutting down Hormuz at 52%, citing data from crowd-sourced prediction platform Polymarket. That same platform, by the way, pegs the chance of the United States officially declaring war on Iran before the end of the month at just 2%.

prices, meanwhile, opened trade this week with an unsurprising gain, with Brent crude trading at over $78 per barrel at the time of writing, and West Texas Intermediate at $75.24 per barrel.

“An oil price jump is expected,” Jorge Leon, head of geopolitical analysis at Rystad Energy, told Reuters. “Even in the absence of immediate retaliation, markets are likely to price in a higher geopolitical risk premium.”

“The direction of oil prices from here will depend on whether there are supply disruptions – which would likely result in higher prices – or if there is a de-escalation in the conflict, resulting in a fading risk premium,” UBS’s Giovanni Staunovo said.

Original Post

Most Popular

More from Author

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

Read Now

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness in eurozone services for the second quarter, this concrete data confirms our expectations that growth between April and June may have been...

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next 12 months could look like the following: 1) More tariffs: threaten big tariffs by Aug 1st, and ‘’close deals’’ with higher tariff rates before...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...